![](/images/graphics-bg.png)
Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations
Joint Authors
Curry, Steven
Logeman, Andrew
Jones, Dwight
Source
Case Reports in Otolaryngology
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-03-24
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Lymphatic malformations are abnormalities that arise in the developing lymphatic system, most frequently presenting in the head and neck.
They are typically treated with sclerotherapy, laser therapy, or surgery for localized lesions.
Sirolimus, an inhibitor of the mammalian target of rapamycin, is a relatively new medical therapy for the treatment of vascular malformations.
This case report presents the improvements and complications seen in a female infant who was diagnosed with a large lymphatic malformation on prenatal ultrasound and has been treated with sirolimus during the first 9 months of life.
American Psychological Association (APA)
Curry, Steven& Logeman, Andrew& Jones, Dwight. 2019. Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations. Case Reports in Otolaryngology،Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1143180
Modern Language Association (MLA)
Curry, Steven…[et al.]. Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations. Case Reports in Otolaryngology No. 2019 (2019), pp.1-3.
https://search.emarefa.net/detail/BIM-1143180
American Medical Association (AMA)
Curry, Steven& Logeman, Andrew& Jones, Dwight. Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations. Case Reports in Otolaryngology. 2019. Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1143180
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1143180